The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Yeon Joo Kim
Research Funding - Merck Sharp & Dohme (Inst)
 
Chang Gon Kim
Honoraria - Astellas Pharma; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Amgen; Astellas Pharma; Johnson & Johnson/Janssen; Novartis; Ono Pharmaceutical; Pfizer
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Dong-A ST; Eisai; Hanmi; Ipsen; Merck; MSD Oncology; Novartis; Takeda
Research Funding - Exelixis (Inst); Handok (Inst); Ipsen (Inst)
 
Youngju Song
No Relationships to Disclose
 
Young Seok Kim
No Relationships to Disclose
 
Jae Lyun Lee
Stock and Other Ownership Interests - Amgen; Johnson & Johnson/Janssen; Karyopharm Therapeutics; Merck; Zymeworks
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Merck; Novartis
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); Arcus Biosciences (Inst); AstraZeneca/MedImmune (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Eutilex (Inst); GI Innovation (Inst); Janssen (Inst); LG Chem (Inst); Loxo/Lilly (Inst); Merck KGaA (Inst); MSD (Inst); Novartis (Inst); Oscotec (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Inkeun Park
Consulting or Advisory Role - Amgen; Astellas Pharma Korea; BMS pharmaceutical Korea; Boryung Pharmaceuticals; Chong Kun Dang Pharmaceutical Co; daiichi sankyo korea; Janssen; Merck; Ono Pharmaceutical; Samsung Bioepis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Boryung Pharmaceutical Co (Inst); Chong Kun Dang Pharmaceutical Co. (Inst)
 
Bumjin Lim
No Relationships to Disclose
 
Ik Jae Lee
No Relationships to Disclose
 
Woong Sub Koom
No Relationships to Disclose
 
Jaeho Cho
No Relationships to Disclose
 
Sang Joon Shin
No Relationships to Disclose
 
Won Sik Ham
No Relationships to Disclose
 
Won Sik Jang
No Relationships to Disclose
 
Ji Eun Heo
No Relationships to Disclose
 
Joo-Hwan Park
No Relationships to Disclose
 
Chan Woo Wee
No Relationships to Disclose
 
Hyunju Kim
No Relationships to Disclose